Inventor · disambiguated record
Benito Munoz
Also filed as: MUNOZ BENITO
66 granted patents·29 pending applications·356 citations·filing 1993–2025
98Inventor score
Files withPROTEOSTASIS THERAPEUTICS INC33BROAD INST INC18MERCK & CO INC10SIBIA NEUROSCIENCES INC8FISCHER CHRISTIAN3
Top patents by PatentIndex Score
95 records- 0197US9745292B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 29, 2017·14 cites·26 claims
- 0296US10017503B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jul 10, 2018·11 cites·28 claims
- 0396US9790219B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Oct 17, 2017·16 cites·38 claims
- 0494US10548878B2Compounds, compositions, and methods of increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Feb 4, 2020·8 cites·23 claims
- 0593US10550106B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Feb 4, 2020·9 cites·13 claims
- 0691US11325913B2Compounds and methods for the treatment of malariaBROAD INST INC·Filed 2020·Granted May 10, 2022·3 cites·20 claims
- 0791US9850262B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2016·Granted Dec 26, 2017·6 cites·25 claims
- 0890US11242361B2Proteasome activity enhancing compoundsPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·2 cites·34 claims
- 0990US10174014B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jan 8, 2019·9 cites·25 claims
- 1089US6051684AMethods of treating neurodegenerative disorders using protease inhibitorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Apr 18, 2000·26 cites·18 claims
- 1188US10137122B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2015·Granted Nov 27, 2018·8 cites·66 claims
- 1288US2024109922A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1387US10662207B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted May 26, 2020·4 cites·27 claims
- 1487US10392378B2Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·7 cites·8 claims
- 1587US10392372B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 27, 2019·6 cites·11 claims
- 1687US9096594B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2013·Granted Aug 4, 2015·9 cites·22 claims
- 1787US2024368198A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1886US10344023B2Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Jul 9, 2019·6 cites·20 claims
- 1986US9738610B2Indazole derivatives and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Aug 22, 2017·7 cites·19 claims
- 2084US10738055B2Compounds and methods for the treatment of malariaBROAD INST INC·Filed 2018·Granted Aug 11, 2020·3 cites·18 claims
- 2183US11052080B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2018·Granted Jul 6, 2021·3 cites·31 claims
- 2283US6967196B1Sulfonamide compounds and uses thereofMERCK & CO INC·Filed 2000·Granted Nov 22, 2005·24 cites·4 claims
- 2381US9890127B2Compounds and compositions for the treatment of cancerBROAD INST INC·Filed 2014·Granted Feb 13, 2018·3 cites·12 claims
- 2480US10059711B2Compounds and methods for the treatment of malariaBROAD INST INC·Filed 2014·Granted Aug 28, 2018·5 cites·14 claims
- 2580US9944607B2Thiohydantoin derivatives and uses thereofWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Apr 17, 2018·3 cites·16 claims
- 2680US2024139158A1Methods of treating pulmonary diseases and disordersPROTEOSTASIS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2779US10738040B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2018·Granted Aug 11, 2020·1 cites·23 claims
- 2878US9120810B2Compounds and methods for the treatment of isocitrate dehydrogenase related diseasesBROAD INST INC·Filed 2013·Granted Sep 1, 2015·2 cites·47 claims
- 2978US5872101AMethods of treating neurodegenerative disorders using protease inhibitorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Feb 16, 1999·27 cites·31 claims
- 3077US6362009B1Solid phase synthesis of heterocyclesMERCK & CO INC·Filed 1997·Granted Mar 26, 2002·21 cites·24 claims
- 3176US11958873B2Proteasome activity enhancing compoundsKINETA INC·Filed 2021·Granted Apr 16, 2024·0 cites·35 claims
- 3276US11136313B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Oct 5, 2021·1 cites·24 claims
- 3376US10738011B2Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosisPROTEOSTASIS THERAPEUTICS INC·Filed 2015·Granted Aug 11, 2020·1 cites·4 claims
- 3475US10899751B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2017·Granted Jan 26, 2021·1 cites·17 claims
- 3575US5962419APeptide and peptide analog protease inhibitorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Oct 5, 1999·19 cites·17 claims
- 3675US5863902AMethods of treating neurodegenerative disorders using protease inhibitorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Jan 26, 1999·22 cites·19 claims
- 3774US7087601B2Metabotropic glutamate receptor-5 modulatorsMERCK & CO INC·Filed 2002·Granted Aug 8, 2006·8 cites·11 claims
- 3873US12319698B2Proteasome activity enhancing compoundsKINETA INC·Filed 2022·Granted Jun 3, 2025·0 cites·22 claims
- 3972US12419885B2Kinase inhibitors and methods of use thereofBROAD INST INC·Filed 2021·Granted Sep 23, 2025·0 cites·42 claims
- 4072US11248010B2Compounds, compositions, and methods for modulating CFTRPROTEOSTASIS THERAPEUTICS INC·Filed 2020·Granted Feb 15, 2022·0 cites·11 claims
- 4172US8183276B2Therapeutic agentsFISCHER CHRISTIAN·Filed 2008·Granted May 22, 2012·1 cites·7 claims
- 4272US7569592B2Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Aug 4, 2009·6 cites·2 claims
- 4372US7332516B2Geminally di-substituted NSAID derivatives as Aβ42 lowering agentsMERCK & CO INC·Filed 2004·Granted Feb 19, 2008·6 cites·7 claims
- 4470US9884851B2Heterocycle-bisamide inhibitors of scavenger receptor BIBROAD INST INC·Filed 2013·Granted Feb 6, 2018·1 cites·11 claims
- 4570US7105533B2Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulatorsMERCK & CO INC·Filed 2003·Granted Sep 12, 2006·6 cites·12 claims
- 4669US11098035B2Compounds, compositions, and methods for increasing CFTR activityPROTEOSTASIS THERAPEUTICS INC·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 4769US2022175735A1Methods of treating pulmonary diseases and disordersPROTEOSTASIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4868US8461162B2Pyrazolo[1,5-a]pyrimidine derivativesSTANTON MATTHEW G·Filed 2008·Granted Jun 11, 2013·1 cites·14 claims
- 4967US2022227739A1Compounds, compositions, and methods for modulating cftrPROTEOSTASIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5066US6015879APeptide and peptide analog protease inhibitorsSIBIA NEUROSCIENCES INC·Filed 1995·Granted Jan 18, 2000·10 cites·23 claims
Showing the top 50 of 95 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Benito Munoz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →